-
Alendronate
- Fosamax*
- Schedule 1
- Bone metabolism regulator
- Tab:40,70mg Solution:Single dose bottles of 70mg
- Prevention and treatment of osteoporosis
-
Allopurinol
- Zyloprim*
- Schedule 1
- Xanthine oxidase inhibitor
- Tab:100,200,300mg
- Treatment of gout associated with hyperuricemia
-
Betahistine
- Serc*
- Schedule 1
- Antivertigo agent
- Tab:16,24mg
- Reduce vertigo episodes associated with Ménière's disease
-
Cyclobenzaprine
- APO-Cyclobenzaprine
- Schedule 1
- Skeletal muscle relaxant
- Tab:10mg
- Treatment of acute muscle spasms
-
Domperidone
- APO-Domperidone
- Schedule 1
- Upper GI motility modifier
- Tab:10mg
- Management of upper GI motility disorders
-
Donepezil
- Aricept
- Schedule 1
- Cholinesterase inhibitor
- Tab:5,10mg
- Treatment of patients with mild to moderate dementia (Alzheimer's type)
-
Dorzolamide
- Trusopt
- Schedule 1
- Carbonic anhydrase inhibitor
- Ophthalmic solution:2%
- Treatment of elevated intraocular pressure (glaucoma)
-
Dorzolamide/Timolol Maleate
- Cosopt
- Schedule 1
- Carbonic anhydrase inhibitor and beta-blocker
- Ophthalmic solution:2% dorz and 0.5% tim
- Treatment of elevated intraocular pressure (glaucoma)
-
Etidronate
- Didronel*
- Schedule 1
- Bone metabolism regulator
- Tab:200mg
- Treatment of osteoporosis
-
Etidronate/Calcium Carbonate
- Didrocal*
- Schedule 1
- Bone metabolism regulator
- Tab:400mg etidronate tabs and 500mg elemental Ca tabs
- Treatment of osteoporosis
-
Folic Acid
- APO-Folic*
- Schedule 1 if single dose is >1mg or packaging suggests daily intake of >1mg
- Bone metabolism regulator
- Tab:0.4,1,5,25mg Cap:0.8mg Injectable:5mg/mL
- Treatment of anemias
-
Galantamine
- Reminyl ER
- Schedule 1
- Cholinesterase inhibitor
- ER Cap:8,16,24mg
- Treatment of patients with mild to moderate dementia (Alzheimer's type)
-
Latanoprost
- Xalatan
- Schedule 1
- Prostaglandin F2 analogue
- Ophthalmic solution:50ug/mL
- Treatment of elevated intraocular pressure (glaucoma)
-
Latanoprost/Timolol Maleate
- Xalatan
- Schedule 1
- Prostaglandin F2 analogue and beta-blocker
- Ophthalmic solution:50ug lata and 5mg tim/mL
- Treatment of elevated intraocular pressure (glaucoma)
-
Oxybutynin
- Ditropan*, Ditropan-XL
- Schedule 1
- Anticholinergic
- ER Tab:5,10mg
- Treatment of urinary incontinence
-
Quinine
- APO-Quinine
- Schedule 1
- Antimalarial
- Tab:200,300mg
- Treatment of malaria
-
Rivastigmine
- Exelon
- Schedule 1
- Cholinesterase inhibitor
- Cap:1.5,3,4.5,6mg Solution:2mg/mL
- Treatment of patients with mild to moderate dementia (Alzheimer's type)
-
Risedronate
- Actonel
- Schedule 1
- Bone metabolism regulator
- Tab:5,30,35,75,150mg EC Tab:35mg
- Treatment of osteoporosis
-
Sildenafil
- Viagra
- Schedule 1
- PDE5 inhibitor
- Tab:25,50,100mg
- Treatment of erectile dysfunction
-
Tadalafil
- Cialis
- Schedule 1
- PDE5 inhibitor
- Tab:2.5,5,10,20mg
- Treatment of erectile dysfunction
-
Tamsulosin Hydrochloride
- Flomax, Flomax CR*
- Schedule 1
- Alpha-1 antagonist
- Tab:0.4mg
- Treatment of benign prostatic hyperplasia
|
|
